US Stock MarketDetailed Quotes

Mineralys Therapeutics (MLYS)

Watchlist
  • 26.620
  • -0.550-2.02%
Close Apr 10 16:00 ET
  • 26.630
  • +0.010+0.04%
Post 20:01 ET
2.19BMarket Cap-11.62P/E (TTM)

Mineralys Therapeutics (MLYS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
231.32%656.64M
231.32%656.64M
125.20%593.63M
4.44%324.92M
1.32%343.03M
-16.22%198.19M
-16.22%198.19M
3.88%263.6M
19.16%311.12M
25.10%338.57M
-Cash and cash equivalents
51.56%172.92M
51.56%172.92M
123.69%217.6M
50.01%101.79M
82.49%165.01M
131.40%114.09M
131.40%114.09M
12.72%97.27M
-32.91%67.86M
-34.60%90.42M
-Short-term investments
475.19%483.71M
475.19%483.71M
126.08%376.03M
-8.28%223.13M
-28.26%178.02M
-55.09%84.1M
-55.09%84.1M
-0.68%166.33M
52.08%243.26M
87.43%248.15M
Other current assets
-33.68%4.75M
-33.68%4.75M
49.38%6.17M
50.35%10.35M
39.08%11.48M
-42.85%7.16M
-42.85%7.16M
-64.45%4.13M
-17.94%6.89M
78.08%8.25M
Total current assets
222.08%661.39M
222.08%661.39M
124.03%599.8M
5.43%335.27M
2.22%354.51M
-17.56%205.35M
-17.56%205.35M
0.89%267.73M
18.00%318M
25.99%346.82M
Non current assets
Net PPE
-28.30%38K
-28.30%38K
-89.86%7K
-47.62%22K
-25.49%38K
--53K
--53K
--69K
--42K
--51K
Investments and advances
----
----
----
----
----
--0
--0
--0
--0
--0
Other non current assets
-23.45%382K
-23.45%382K
-68.14%144K
-3.56%433K
4.75%397K
878.43%499K
878.43%499K
786.27%452K
780.39%449K
871.79%379K
Total non current assets
-23.91%420K
-23.91%420K
-71.02%151K
-7.33%455K
1.16%435K
-78.21%552K
-78.21%552K
-95.72%521K
-97.74%491K
-98.62%430K
Total assets
221.42%661.81M
221.42%661.81M
123.65%599.95M
5.41%335.72M
2.22%354.94M
-18.17%205.9M
-18.17%205.9M
-3.35%268.25M
9.37%318.49M
13.32%347.25M
Liabilities
Current liabilities
Payables
321.09%2.02M
321.09%2.02M
-63.91%1.12M
85.35%3.16M
-91.25%373K
-20.30%479K
-20.30%479K
-44.27%3.11M
-22.27%1.71M
78.51%4.26M
-accounts payable
321.09%2.02M
321.09%2.02M
-63.91%1.12M
85.35%3.16M
-91.25%373K
-20.30%479K
-20.30%479K
-44.27%3.11M
-22.27%1.71M
78.51%4.26M
Current accrued expenses
-28.62%7.56M
-28.62%7.56M
-29.08%18.52M
-35.38%16.39M
-16.93%11.86M
27.81%10.59M
27.81%10.59M
227.62%26.11M
680.91%25.36M
83.28%14.28M
Current liabilities
3.19%15.11M
3.19%15.11M
-24.91%23.52M
-21.92%22.17M
-30.30%13.39M
39.73%14.65M
39.73%14.65M
131.27%31.32M
357.50%28.4M
81.86%19.2M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
3.19%15.11M
3.19%15.11M
-24.91%23.52M
-21.92%22.17M
-30.30%13.39M
39.73%14.65M
39.73%14.65M
131.27%31.32M
357.50%28.4M
81.86%19.2M
Shareholders'equity
Share capital
60.00%8K
60.00%8K
60.00%8K
20.00%6K
20.00%6K
25.00%5K
25.00%5K
25.00%5K
25.00%5K
25.00%5K
-common stock
60.00%8K
60.00%8K
60.00%8K
20.00%6K
20.00%6K
25.00%5K
25.00%5K
25.00%5K
25.00%5K
25.00%5K
Retained earnings
-51.12%-457.17M
-51.12%-457.17M
-67.58%-424.94M
-96.73%-388M
-120.67%-344.73M
-142.58%-302.52M
-142.58%-302.52M
-152.77%-253.57M
-154.30%-197.23M
-138.80%-156.22M
Paid-in capital
123.56%1.1B
123.56%1.1B
104.15%1B
43.96%701.55M
41.72%686.28M
34.96%493.77M
34.96%493.77M
34.63%490.5M
34.41%487.32M
34.04%484.26M
Total stockholders'equity
238.13%646.69M
238.13%646.69M
143.29%576.43M
8.09%313.55M
4.12%341.56M
-20.69%191.26M
-20.69%191.26M
-10.26%236.93M
1.78%290.1M
10.87%328.05M
Total equity
238.13%646.69M
238.13%646.69M
143.29%576.43M
8.09%313.55M
4.12%341.56M
-20.69%191.26M
-20.69%191.26M
-10.26%236.93M
1.78%290.1M
10.87%328.05M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 231.32%656.64M231.32%656.64M125.20%593.63M4.44%324.92M1.32%343.03M-16.22%198.19M-16.22%198.19M3.88%263.6M19.16%311.12M25.10%338.57M
-Cash and cash equivalents 51.56%172.92M51.56%172.92M123.69%217.6M50.01%101.79M82.49%165.01M131.40%114.09M131.40%114.09M12.72%97.27M-32.91%67.86M-34.60%90.42M
-Short-term investments 475.19%483.71M475.19%483.71M126.08%376.03M-8.28%223.13M-28.26%178.02M-55.09%84.1M-55.09%84.1M-0.68%166.33M52.08%243.26M87.43%248.15M
Other current assets -33.68%4.75M-33.68%4.75M49.38%6.17M50.35%10.35M39.08%11.48M-42.85%7.16M-42.85%7.16M-64.45%4.13M-17.94%6.89M78.08%8.25M
Total current assets 222.08%661.39M222.08%661.39M124.03%599.8M5.43%335.27M2.22%354.51M-17.56%205.35M-17.56%205.35M0.89%267.73M18.00%318M25.99%346.82M
Non current assets
Net PPE -28.30%38K-28.30%38K-89.86%7K-47.62%22K-25.49%38K--53K--53K--69K--42K--51K
Investments and advances ----------------------0--0--0--0--0
Other non current assets -23.45%382K-23.45%382K-68.14%144K-3.56%433K4.75%397K878.43%499K878.43%499K786.27%452K780.39%449K871.79%379K
Total non current assets -23.91%420K-23.91%420K-71.02%151K-7.33%455K1.16%435K-78.21%552K-78.21%552K-95.72%521K-97.74%491K-98.62%430K
Total assets 221.42%661.81M221.42%661.81M123.65%599.95M5.41%335.72M2.22%354.94M-18.17%205.9M-18.17%205.9M-3.35%268.25M9.37%318.49M13.32%347.25M
Liabilities
Current liabilities
Payables 321.09%2.02M321.09%2.02M-63.91%1.12M85.35%3.16M-91.25%373K-20.30%479K-20.30%479K-44.27%3.11M-22.27%1.71M78.51%4.26M
-accounts payable 321.09%2.02M321.09%2.02M-63.91%1.12M85.35%3.16M-91.25%373K-20.30%479K-20.30%479K-44.27%3.11M-22.27%1.71M78.51%4.26M
Current accrued expenses -28.62%7.56M-28.62%7.56M-29.08%18.52M-35.38%16.39M-16.93%11.86M27.81%10.59M27.81%10.59M227.62%26.11M680.91%25.36M83.28%14.28M
Current liabilities 3.19%15.11M3.19%15.11M-24.91%23.52M-21.92%22.17M-30.30%13.39M39.73%14.65M39.73%14.65M131.27%31.32M357.50%28.4M81.86%19.2M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 3.19%15.11M3.19%15.11M-24.91%23.52M-21.92%22.17M-30.30%13.39M39.73%14.65M39.73%14.65M131.27%31.32M357.50%28.4M81.86%19.2M
Shareholders'equity
Share capital 60.00%8K60.00%8K60.00%8K20.00%6K20.00%6K25.00%5K25.00%5K25.00%5K25.00%5K25.00%5K
-common stock 60.00%8K60.00%8K60.00%8K20.00%6K20.00%6K25.00%5K25.00%5K25.00%5K25.00%5K25.00%5K
Retained earnings -51.12%-457.17M-51.12%-457.17M-67.58%-424.94M-96.73%-388M-120.67%-344.73M-142.58%-302.52M-142.58%-302.52M-152.77%-253.57M-154.30%-197.23M-138.80%-156.22M
Paid-in capital 123.56%1.1B123.56%1.1B104.15%1B43.96%701.55M41.72%686.28M34.96%493.77M34.96%493.77M34.63%490.5M34.41%487.32M34.04%484.26M
Total stockholders'equity 238.13%646.69M238.13%646.69M143.29%576.43M8.09%313.55M4.12%341.56M-20.69%191.26M-20.69%191.26M-10.26%236.93M1.78%290.1M10.87%328.05M
Total equity 238.13%646.69M238.13%646.69M143.29%576.43M8.09%313.55M4.12%341.56M-20.69%191.26M-20.69%191.26M-10.26%236.93M1.78%290.1M10.87%328.05M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More